Pen Needles Market Size, Industry Analysis and Forecast

According to the new market research report Pen Needles Market by Type (Standard Pen Needles and Safety Pen Needles), Needle Length (4mm, 5mm, 6mm, 8mm, 10mm, 12mm), Therapy (Insulin, GLP-1, Growth Hormone, and Others), Mode of Purchase (Retail, Non-Retail) — Global Forecasts to 2023, published by MarketsandMarkets™, the Pen Needles Market is expected to reach USD 3.4 billion by 2023 from an estimated USD 2.0 billion in 2018, at a CAGR of 11.0% during the forecast period (2018–2023).

Download PDF Brochure:

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=7594861

Growth in the Pen Needles Market is mainly driven by factors such as the growing prevalence of chronic diseases and the favorable reimbursement scenario in selected countries. The growing preference for biosimilar drugs is another factor providing a wide range of growth opportunities for key players in the market.

The standard Pen Needles segment is expected to account for the largest share of the market in 2018

On the basis of type, the market is segmented into standard and safety Pen Needles. In 2018, the standard Pen Needles segment is expected to account for the largest share of the Pen Needles Market. Growth in this market is attributed to the low cost of standard Pen Needles.

Browse and in-depth TOC on “Pen Needles Market

87 — Tables

46 — Figures

144 — Pages

The insulin therapy segment is expected to grow at the highest CAGR during the forecast period

On the basis of therapy, the Pen Needles Market is categorized into insulin therapy, glucagon-like peptide-1 (GLP-1) therapy, growth hormone therapy, and other therapies. The insulin therapy segment is expected to grow at the highest CAGR during the forecast period due to the high and growing diabetic population globally.

Europe dominated the Pen Needles Market in 2018

Europe is expected to dominate the Market in 2018. The large share of the European Pen Needles Market can primarily be attributed to the high diabetes expenditure and reimbursement in Germany, NHS support and access to Pen Needles at a subsidized cost in the UK, high insurance coverage in France, and supportive regulations in Spain.

Request Research Sample Pages:

https://www.marketsandmarkets.com/requestsampleNew.asp?id=75948613

The key players in the Pen Needles Market are Becton, Dickinson and Company (US), Novo Nordisk A/S (Denmark), Ypsomed Holding AG (Switzerland), B. Braun Melsungen AG (Germany), HTL-STREFA S.A. (Poland), Terumo Corporation (Japan), and Owen Mumford (UK).

Comments

comments

You may also like...

Leave a Reply

Your email address will not be published. Required fields are marked *